Access the full text.
Sign up today, get DeepDyve free for 14 days.
Elizabeth Meredith, M. Holder, A. Rosén, Adrian Lee, M. Dyer, N. Barnes, J. Gordon (2006)
Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin’s lymphomaProceedings of the National Academy of Sciences, 103
I. Tetko, V. Tanchuk (2002)
Application of Associative Neural Networks for Prediction of Lipophilicity in ALOGPS 2.1 ProgramJournal of chemical information and computer sciences, 42 5
A. Serafeim, G. Grafton, A. Chamba, C. Gregory, R. Blakely, N. Bowery, N. Barnes, J. Gordon (2002)
5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.Blood, 99 7
C. Montiel-Duarte, E. Ansorena, M. López-Zabalza, E. Cenarruzabeitia, M. Iraburu (2004)
Role of reactive oxygen species, glutathione and NF-κB in apoptosis induced by 3,4-methylenedioxymethamphetamine (“Ecstasy”) on hepatic stellate cellsBiochemical Pharmacology, 67
J. Capela, H. Carmo, F. Remião, M. Bastos, A. Meisel, F. Carvalho (2009)
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An OverviewMolecular Neurobiology, 39
R. Simantov, Miriam Tauber (1997)
The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cellsThe FASEB Journal, 11
Marc Maliepaard, N. Mol, Lambert Janssen, W. Neut, W. Verboom, D. Reinhoudt (1992)
Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compounds.Anti-cancer drug design, 7 5
David Adams, Mateus Silva, J. Flowers, G. Kohlhagen, Y. Pommier, O. Colvin, G. Manikumar, M. Wani (2005)
Camptothecin analogs with enhanced activity against human breast cancer cells. I. Correlation of potency with lipophilicity and persistence in the cleavage complexCancer Chemotherapy and Pharmacology, 57
A. Serafeim, M. Holder, G. Grafton, A. Chamba, M. Drayson, Q. Luong, C. Bunce, C. Gregory, N. Barnes, J. Gordon (2003)
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.Blood, 101 8
T. Montgomery, C. Buon, S. Eibauer, P. Guiry, A. Keenan, G. McBean (2007)
Comparative potencies of 3,4‐methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5‐HT transport in mammalian cell linesBritish Journal of Pharmacology, 152
B. Smart (2001)
Fluorine substituent effects (on bioactivity)Journal of Fluorine Chemistry, 109
C Davidson, A Gow, T Lee, E Ellinwood (2001)
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatmentBrain Res Brain Res Rev, 36
Monika Huszar, Attila Varga, Anikó Horváth, Tamás Lóránd, Attila Agócs, M. Idei, J. Mandl, T. Vántus, G. Kéri (2010)
Comparative characterization of experimental and calculated lipophilicity and anti-tumour activity of isochromanone derivatives.Current medicinal chemistry, 17 4
I. Tetko, Pierre Bruneau (2004)
Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database.Journal of pharmaceutical sciences, 93 12
(1999)
Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells
L. Steward, J. Ge, K. Bentley, P. Barber, A. Hope, J. Lambert, J. Peters, T. Blackburn (1995)
Evidence that the atypical 5‐HT3 receptor ligand, [3H]‐BRL46470, labels additional 5‐HT3 binding sites compared to [3H]‐granisetronBritish Journal of Pharmacology, 116
J. Christman, David Miller, Peter Coward, Lloyd Smith, N. Teng (1990)
Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies.Gynecologic oncology, 39 1
B. Yamamoto, Michael Bankson (2005)
Amphetamine neurotoxicity: cause and consequence of oxidative stress.Critical reviews in neurobiology, 17 2
N. Blatt, Anthony Boitano, C. Lyssiotis, A. Opipari, G. Glick (2009)
Bz-423 superoxide signals B cell apoptosis via Mcl-1, Bak, and Bax.Biochemical pharmacology, 78 8
Elizabeth Meredith, A. Chamba, M. Holder, N. Barnes, J. Gordon (2005)
Close encounters of the monoamine kind: immune cells betray their nervous dispositionImmunology, 115
A. Cornish-Bowden, Daniel Koshland (1975)
Diagnostic uses of the Hill (Logit and Nernst) plots.Journal of molecular biology, 95 2
C. Verrico, G. Miller, B. Madras (2006)
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatmentPsychopharmacology, 189
K. Sanderson, L. Butler, V. Ingram (1997)
Aggregates of a beta-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's disease.Brain research, 744 1
HJ Bohm, D Banner, S Bendels, M Kansy, B Kuhn, K Muller, U Obst-Sander, M Stahl (2004)
Fluorine in medicinal chemistryChembiochem, 5
L. Biasutto, Lan-Feng Dong, M. Zoratti, J. Neuzil (2010)
Mitochondrially targeted anti-cancer agents.Mitochondrion, 10 6
B. Callahan, B. Cord, Jie Yuan, U. Mccann, G. Ricaurte (2001)
Inhibitors of Na+/H+ and Na+/Ca2+ exchange potentiate methamphetamine‐induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicityJournal of Neurochemistry, 77
T. Monks, Douglas Jones, F. Bai, S. Lau (2004)
The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicityTherapeutic Drug Monitoring, 26
N. Milhazes, Teresa Cunha-Oliveira, P. Martins, J. Garrido, Catarina Oliveira, A. Rego, F. Borges (2006)
Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship.Chemical research in toxicology, 19 10
I. Tetko, J. Gasteiger, R. Todeschini, A. Mauri, D. Livingstone, P. Ertl, V. Palyulin, E. Radchenko, N. Zefirov, A. Makarenko, V. Tanchuk, V. Prokopenko (2005)
Virtual Computational Chemistry Laboratory – Design and DescriptionJournal of Computer-Aided Molecular Design, 19
P. Keizers, C. Graaf, F. Kanter, C. Oostenbrink, K. Feenstra, J. Commandeur, N. Vermeulen (2005)
Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation.Journal of medicinal chemistry, 48 19
PTLD Post-transplant lymphoproliferative disease SERT Serotonin transporter
D. Nichols, A. Hoffman, R. Oberlender, P. Jacob, A. Shulgin (1986)
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.Journal of medicinal chemistry, 29 10
J. Cadet, I. Krasnova, S. Jayanthi, Johnalyn Lyles (2007)
Neurotoxicity of substituted amphetamines: Molecular and cellular mechanismsNeurotoxicity Research, 11
K. Sanderson, L. Butler, V. Ingram (1997)
Aggregates of a β-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's diseaseBrain Research, 744
J. Nash, David Nichols, J. Nash (1991)
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.European journal of pharmacology, 200 1
A. Chamba, M. Holder, R. Jarrett, Lesley Shield, K. Toellner, M. Drayson, N. Barnes, J. Gordon (2010)
SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.Leukemia research, 34 8
Bryan Yamamoto, Wenjun Zhu (1998)
The effects of methamphetamine on the production of free radicals and oxidative stress.The Journal of pharmacology and experimental therapeutics, 287 1
C. Davidson, A. Gow, Tong Lee, E. Ellinwood (2001)
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatmentBrain Research Reviews, 36
Lars Söderberg, L. Haag, P. Höglund, B. Roth, P. Stenberg, M. Wahlgren (2009)
The effects of lipophilic substances on the shape of erythrocytes demonstrated by a new in vitro-method.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 36 4-5
Elizabeth Meredith, M. Holder, A. Chamba, A. Challa, Adrian Lee, C. Bunce, M. Drayson, G. Pilkington, R. Blakely, M. Dyer, N. Barnes, J. Gordon (2005)
The serotonin transporter (SLC6A4) is present in B‐cell clones of diverse malignant origin: probing a potential antitumor target for psychotropicsThe FASEB Journal, 19
S. Hayat, Robert Williams, M. Rattray (2006)
Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitroJournal of Psychopharmacology, 20
U. Braun, Shulgin At, G. Braun (1980)
[Research on the central activity and analgesia of N-substituted analogs of the amphetamine derivative 3,4-methylenedioxyphenylisopropylamine].Arzneimittel-Forschung, 30 5
Michael Gandy, Matthew McIldowie, Katie Lewis, Agata Wasik, D. Salomonczyk, Keith Wagg, Zak Millar, David Tindiglia, P. Huot, T. Johnston, S. Thiele, Blake Nguyen, N. Barnes, J. Brotchie, M. Martin-Iverson, J. Nash, J. Gordon, M. Piggott (2010)
Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicityMedChemComm, 1
Jeff Beckman, Qixin Wang, P. Guengerich (2008)
Kinetic Analysis of Correct Nucleotide Insertion by a Y-family DNA Polymerase Reveals Conformational Changes Both Prior to and following Phosphodiester Bond Formation as Detected by Tryptophan Fluorescence*Journal of Biological Chemistry, 283
U. Braun, A. Shulgin, Gisela Braun (1980)
Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine).Journal of pharmaceutical sciences, 69 2
While 3,4-methylenedioxymethamphetamine (MDMA/‘ecstasy’) is cytostatic towards lymphoma cells in vitro, the concentrations required militate against its translation directly to a therapeutic in vivo. The possibility of ‘redesigning the designer drug’, separating desired anti-lymphoma activity from unwanted psychoactivity and neurotoxicity, was therefore mooted. From an initial analysis of MDMA analogues synthesized with a modified α-substituent, it was found that incorporating a phenyl group increased potency against sensitive, Bcl-2-deplete, Burkitt’s lymphoma (BL) cells 10-fold relative to MDMA. From this lead, related analogs were synthesized with the ‘best’ compounds (containing 1- and 2-naphthyl and para-biphenyl substituents) some 100-fold more potent than MDMA versus the BL target. When assessed against derived lines from a diversity of B-cell tumors MDMA analogues were seen to impact the broad spectrum of malignancy. Expressing a BCL2 transgene in BL cells afforded only scant protection against the analogues and across the malignancies no significant correlation between constitutive Bcl-2 levels and sensitivity to compounds was observed. Bcl-2-deplete cells displayed hallmarks of apoptotic death in response to the analogues while BCL2 overexpressing equivalents died in a caspase-3-independent manner. Despite lymphoma cells expressing monoamine transporters, their pharmacological blockade failed to reverse the anti-lymphoma actions of the analogues studied. Neither did reactive oxygen species account for ensuing cell death. Enhanced cytotoxic performance did however track with predicted lipophilicity amongst the designed compounds. In conclusion, MDMA analogues have been discovered with enhanced cytotoxic efficacy against lymphoma subtypes amongst which high-level Bcl-2—often a barrier to drug performance for this indication—fails to protect.
Investigational New Drugs – Springer Journals
Published: Aug 18, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.